Information Centers

Our Information Centers are resources for members of the media who are interested in news and information related to Merck's contributions in fighting these diseases:

Media Center

Assets intended for use by media professionals.

For general media inquiries only, please call +1 908-740-5633 or e-mail Media Relations. Members of the media seeking information on a specific topic may also contact the following individuals:

Kelley Dougherty

Title: Global Reputation, Branding and Digital Media
Office Phone: +1 267-305-3552
Email: kelley_dougherty@merck.com

Scott Wright

Title: Enterprise Social Media
Office Phone: +1 267-305-3581
Email: scott.wright@merck.com

Tracy Ogden

Title: Global Media Relations and Executive Communications
Office Phone: +1 908-740-1747
Email: tracy_ogden@merck.com

Pamela Eisele

Title: Product, Pipeline & Supply Media Relations
Office Phone: +1 267-305-3558
Email: pamela_eisele@merck.com

Doris Li

Title: Product, Pipeline & Supply Media Relations
Office Phone: +1 908-740-1903
Email: Doris.Li@merck.com

Claire Gillespie

Title: Corporate Media Relations
Office Phone: +1 267-305-0932
Email: claire.gillespie@merck.com

 

Additional Contacts

Consumers:

For consumer or patient-related questions, please contact your physician, pharmacist or other health care provider.

To report an adverse experience with a specific Merck product, please call the Merck National Service Center at +1 800-672-6372.

Health Care Professionals:

If you are a physician, pharmacist or other health care provider and have a question(s) or need information about a specific Merck product or service, please call the Merck National Service Center for Health Care Professionals at +1 866-448-7590.

For Stock Holders:

Tel: +1 800-522-9114
Monday-Friday, 7AM – 7 PM CST

For Institutional Investors and Analysts:

Tel: +1 908-423-5881
Monday-Friday, 8:30 AM – 4 PM ET

Merck Corporate

Photography

Keytruda

Kenneth C. Frazier

ISENTRESS HD

Company Snapshot

From developing new therapies that treat and prevent disease to helping people in need, we're committed to improving health and well-being around the world. Visit our About Us section.

 
COMPANY FACT SHEET

Everything you need to know about Merck.

PIPELINE

Our pipeline is continually evolving and is updated quarterly.

OUR LEADERSHIP

How we govern ourselves as a company is as important as anything else we do.

Join the Conversation

Connect with us on Facebook, Twitter, and LinkedIn to learn more about our corporate initiatives, including those in health and wellness, philanthropy and corporate responsibility.

Scott M. Wright, Social Media +1 267-305-3581 Scott.Wright@merck.com

Please read our social media guidelines.

Check out our latest #oncology news from our collaboration with : https://t.co/E5iEAGcX9a-1 hour 37 min ago
An estimated 9 out of 10 people in the U.S. struggle to understand health information. We're helping to change that… https://t.co/eLAUNpfgeJ-8 hours 23 min ago
Thank you for bringing this matter to our attention. We take these allegations very seriously & will thoro… https://t.co/fl39BmmanP-1 day 1 min ago
We've been working to discover and develop #vaccines for more than a century: https://t.co/pTpLSSZEVU https://t.co/wwma96M0hg-1 day 6 hours ago
#DYK that nearly 30 million Americans have #diabetes? #FocusonA1C https://t.co/vLJ6RI1Z12-2 days 5 hours ago
Merck
Type 2 diabetes occurs when the body cannot use insulin effectively and/or the body cannot produce enough insulin. In America, almost 30 million people have diabetes. #FocusonA1C
about 2 days 5 hours ago
Merck
We were on the ground at Aspen Ideas Festival with Merck for Mothers to discuss ideas and issues that shape our lives. Wondering what it was like? Our scholars can tell you: b​i​t​.​l​y​/​2​w​y​I​W​G​P
about 6 days 23 hours ago
Merck
Swapnil Rajpathak, M.D., provides his point of view on the importance of early intervention for people with diabetes, to help lower their A1C and get to goal as soon as possible after diagnosis. #FocusonA1C
about 2 weeks 2 days ago